Dahan Michel has filed 13 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 34840 shares of Akebia Therapeutics, Inc. ($AKBA) on May 13, 2024.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 34840 | $1.26 | 672,092.0000 | 187,465,448 | 4.93% | 0.02% |
| Feb. 29, 2024 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 8661 | $1.58 | 706,932.0000 | 187,465,448 | 1.21% | 0.00% |
| Feb. 27, 2024 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 10744 | $1.52 | 715,593.0000 | 187,465,448 | 1.48% | 0.01% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | A | Common Stock | 149300 | $0.00 | 726,337.0000 | 187,465,448 | 25.87% | 0.08% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | A | Stock Option (Right to buy) | 224000 | $0.00 | 224,000.0000 | 187,465,448 | 9999.99% | 0.12% |
| May 24, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | A | Common Stock | 200000 | $0.00 | 669,515.0000 | 0 | 42.60% | 0.00% |
| May 25, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 95478 | $1.22 | 574,037.0000 | 0 | 14.26% | 0.00% |
| May 24, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | A | Employee Stock Option (Right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | A | Common Stock | 200000 | $0.00 | 469,515.0000 | 0 | 74.21% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 8058 | $0.88 | 281,869.0000 | 0 | 2.78% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 10476 | $0.88 | 271,393.0000 | 0 | 3.72% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 1878 | $0.88 | 269,515.0000 | 0 | 0.69% | 0.00% |
| Feb. 27, 2023 | Akebia Therapeutics, Inc. | $AKBA | Dahan Michel | SVP, Chief Operating Officer | S | Common Stock | 10090 | $0.81 | 289,927.0000 | 0 | 3.36% | 0.00% |